CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 1,147,475	$ 1,653
Adjustments to reconcile net income to net cash used by operating activities:
Depreciation and amortization	451,207	442,408
Accretion of asset retirement obligation	11,412	1,732
Common stock payable for directors fees	75,000	56,250
Gain on settlement of Hillgrove advance	0	(113,422)
Gain on forgiveness of Cares Act debt	0	(443,400)
Write down of inventory to net realizable value	136,836	66,054
Change in fair value of investments	93,458	0
Changes in operating assets and liabilities:
Accounts receivable	(713,346)	(362,681)
Inventories	328,380	17,448
Prepaid expenses	(60,916)	0
IVA receivable and other assets	(86,442)	(15,402)
Accounts payable	(706,155)	(519,570)
Accrued liabilities	64,045	(92,927)
Export tax assessment payable	0	(1,120,730)
Payable to related parties	4,084	(154,022)
Net cash provided (used) by operating activities	745,038	(2,236,609)
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from redemption of certificates of deposit	0	210,184
Purchase of investments	(13,789,772)	0
Proceeds from sales of investments	396,921	0
Purchase of properties, plants and equipment	(382,999)	(115,127)
Net cash provided (used) by investing activities	(13,775,850)	95,057
CASH FLOWS FROM FINANCING ACTIVITIES:
Change in checks issued and payable	0	(86,685)
Payments on advances from related party	0	(56,416)
Proceeds from issuance of common stock, net of issuance costs	0	23,342,180
Proceeds from exercise of warrants	0	1,790,703
Payments on Hillgrove advances payable	0	(1,020,799)
Principal paid on notes payable to bank	0	(100,000)
Principal payments of long-term debt	(19,767)	(27,926)
Net cash provided (used) by financing activities	(19,767)	23,841,057
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH	(13,050,579)	21,699,505
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD	21,420,329	722,377
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD	8,369,750	22,421,882
NON-CASH FINANCING AND INVESTING ACTIVITIES:
Equipment purchased with note payable	161,600	0
Common stock payable to directors	0	130,483
Payable to related party satisfied with exercise of stock purchase warrants	$ 0	$ 62,500